Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores

Inhaled Colistin in Patients with Bronchiectasis and ChronicPseudomonas aeruginosaInfection

(2014) Charles S. Haworth et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A Preliminary Quality of Life Questionnaire-Bronchiectasis

(2014) Alexandra L. Quittner et al.   CHEST

Bronchiectasis: an update on current pharmacotherapy and future perspectives

(2014) Manjit K Sidhu et al.   EXPERT OPINION ON PHARMACOTHERAPY

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials

(2014) Alan F Barker et al.   Lancet Respiratory Medicine

Non–Cystic Fibrosis Bronchiectasis

(2013) Pamela J. McShane et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Validation of a Quality of Life Questionnaire for Bronchiectasis: psychometric analyses of the Spanish QOL-B-V3.0

(2013) Casilda Olveira et al.   QUALITY OF LIFE RESEARCH

Evaluating Success of Therapy for Bronchiectasis

(2012) Maeve P. Smith et al.   CLINICS IN CHEST MEDICINE

Clinical challenges in managing bronchiectasis

(2009) Kenneth W. TSANG et al.   RESPIROLOGY

Bronchiectasis

(2008) Anne E. O'Donnell   CHEST

Update on non-cystic fibrosis bronchiectasis

(2008) Diana Bilton   CURRENT OPINION IN PULMONARY MEDICINE

Interpretation of treatment changes in 6-minute walk distance in patients with COPD

(2008) M. A. Puhan et al.   EUROPEAN RESPIRATORY JOURNAL

Clinical determinants of the 6-Minute Walk Test in bronchiectasis

(2008) A.L. Lee et al.   RESPIRATORY MEDICINE

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

(2007) Dennis Revicki et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY